CG-TARGET

CG-TARGET predicts biological process targets of chemical compounds by integrating chemical-genetic interaction profiles with genome-wide genetic interaction networks.


Key Features:

  • Interaction Profile Integration: Combines large-scale chemical-genetic interaction screening data with genetic interaction networks to infer biological processes perturbed by compounds.
  • High-Throughput Chemical Screening Analysis: Processes chemical-genetic interaction profiles from large compound libraries, including screens of nearly 14,000 compounds in Saccharomyces cerevisiae.
  • False Discovery Rate Control: Improves control of false discovery rates in biological process prediction compared with enrichment-based approaches.
  • Negative Interaction Prioritization: Utilizes negative chemical-genetic interactions as primary contributors to high-confidence biological process predictions.

Scientific Applications:

  • Compound Functional Annotation: Identifies cellular biological processes perturbed by chemical compounds using chemical-genetic interaction data.
  • Drug Mechanism Investigation: Supports discovery of compound mechanisms of action, including identification of inhibitors affecting processes such as tubulin polymerization and cell cycle progression.

Methodology:

CG-TARGET generates chemical-genetic interaction profiles by measuring mutant fitness defects after compound treatment and integrates these profiles with genome-wide genetic interaction networks to predict perturbed biological processes.

Topics

Details

Tool Type:
library
Programming Languages:
R
Added:
1/20/2021
Last Updated:
5/13/2021

Operations

Publications

Simpkins SW, Nelson J, Deshpande R, Li SC, Piotrowski JS, Wilson EH, Gebre AA, Safizadeh H, Okamoto R, Yoshimura M, Costanzo M, Yashiroda Y, Ohya Y, Osada H, Yoshida M, Boone C, Myers CL. Predicting bioprocess targets of chemical compounds through integration of chemical-genetic and genetic interactions. PLOS Computational Biology. 2018;14(10):e1006532. doi:10.1371/journal.pcbi.1006532. PMID:30376562. PMCID:PMC6226211.

PMID: 30376562
PMCID: PMC6226211
Funding: - National Human Genome Research Institute: R01HG005084 - National Institute of General Medical Sciences: R01GM104975, T32GM008347 - National Science Foundation: 00039202, DBI 0953881 - RIKEN: 201601100228, FY2017 Incentive Research Projects Grant, Foreign Postdoctoral Research Fellowship - Ministry of Education, Culture, Sports, Science and Technology: 15H04402 - Japan Society for the Promotion of Science: 15H04483, 17H06411